Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-17T16:16:17.917Z Has data issue: false hasContentIssue false

Chapter 18 - Radiation Therapy

Published online by Cambridge University Press:  02 November 2018

Sulpicio G. Soriano
Affiliation:
Boston Children’s Hospital
Craig D. McClain
Affiliation:
Boston Children’s Hospital
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Howlader, N, Noone, AM, Krapcho, M, Miller, D, Bishop, K, Altekruse, SF, et al., eds. SEER Cancer Statistics Review, 1975–2013. Bethesda, MD: National Cancer Institute; April 2016. Available at http://seer.cancer.gov/csr/1975_2013/.Google Scholar
Milano, MT, Constine, LS, Okunieff, P. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol. 2007;17:131–40.CrossRefGoogle ScholarPubMed
Knab, B, Connell, PP. Radiotherapy for pediatric brain tumors: when and how. Expert Rev Anticancer Ther. 2007;7:S6977.CrossRefGoogle ScholarPubMed
Gibbs, IC, Tuamokumo, N, Yock, TI. Role of radiation therapy in pediatric cancer. Hematol Oncol Clin North Am. 2006;20:455–70.CrossRefGoogle ScholarPubMed
Kirsch, DG, Tarbell, NJ. Conformal radiation therapy for childhood tumors. Oncologist. 2004;9:442–50.Google Scholar
Lowenthal, RM, Eaton, K. Toxicity of chemotherapy. Hematol Oncol Clin North Am. 1996;10:967–90.Google Scholar
Ullrich, NJ, Robertson, R, Kinnamon, DD, Scott, RM, Kieran, MW, Turner, CD, et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 2007;68(12):932–8.Google Scholar
Hall, EJ, Wuu, CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys. 2003;56:83–8.CrossRefGoogle ScholarPubMed
Anghelescu, DL, Burgoyne, LL, Liu, W, Hankins, GM, Cheng, C, Beckham, PA, et al. Safe anesthesia for radiotherapy in pediatric oncology: St Jude Children’s Research Hospital experience, 2004–2006. Int J Radiat Oncol Biol Phys. 2008;71:491–7.Google Scholar
Gottschling, S. Propofol versus midazolam/ketamine for procedural sedation in pediatric oncology. J Pediatr Hematol Oncol. 2005;27(9):471–6.Google Scholar
McDowall, RH, Scher, CS, Barst, SM. Total intravenous anesthesia for children undergoing brief diagnostic procedures. J Clin Anesth. 1995;7:273–80.Google Scholar
Buehrer, S, Immoos, S, Frei, M, Timmermann, B, Weiss, M. Evaluation of propofol for repeated prolonged deep sedation in children undergoing proton radiation therapy. Br J Anaesth. 2007;99(4): 556–60.Google Scholar
Westrin, P. The induction dose of propofol in infants 1–6 months of age and in children 10–16 years of age. Anesthesiology. 1991;74(3):455–8.Google Scholar
Aun, CST. Induction dose-response of propofol in unpremedicated children. Br J Anaesth. 1992;68(1): 64–7.Google Scholar
Keidan, I, Peral, A, Shabtai, EL, Pfeffer, RM. Children undergoing repeated exposures for radiation therapy do not develop tolerance to propofol: clinical and bispectral index data. Anesthesiology. 2004;100(2): 251–4.Google Scholar
Pellier, I, Monrigal, JP, Le Moine, P, Rod, B, Rialland, X, Granry, JC. Use of intravenous ketamine–midazolam association for pain procedures in children with cancer. A prospective study. Paediatr Anaesth. 1999;9:61–8.Google Scholar
Haeseler, G, Zuzan, O, Kohn, G, Piepenbrock, S, Leuwer, M. Anesthesia with midazolam and S-(+)-ketamine in spontaneously breathing patients during magnetic resonance imaging. Paediatr Anaesth. 2000;10:513–19.Google Scholar
Tobias, JD, Phipps, S, Smith, B, Mulhern, RK. Oral ketamine premedication to alleviate the distress of invasive procedures in pediatric oncology patients. Pediatrics. 1992;90:537–41.Google Scholar
Virtanen, R. Characterization of the selectivity, specificity, and potency of Dexmedetomidine as an α2-adrenoceptor agonist. Eur J Pharmacol. 1988;150:914.Google Scholar
Shukry, M, Miller, JA. Update on dexmedetomidine: use in nonintubated patients requiring sedation for surgical procedures.Ther Clin Risk Manag. 2010;6:111–21.Google ScholarPubMed
Shukry, M, Ramadhyani, U. Dexmedetomidine as the primary sedative agent for brain radiation therapy in a 21-month old child. Paediatr Anesth. 2005;15(3):241–2.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×